177 filings
Page 5 of 9
8-K
8mnj4u1403cet
2 Nov 20
Rhythm Pharmaceuticals Reports Third Quarter 2020 Financial Results
9:32am
8-K
tqug5mo
16 Sep 20
Departure of Directors or Certain Officers
4:01pm
CT ORDER
0tvjvt332zhome 6qer5
17 Aug 20
Confidential treatment order
3:16pm
8-K
liikucj 6bx4adk
3 Aug 20
Rhythm Pharmaceuticals Reports Second Quarter 2020 Financial Results
9:25am
8-K
41n3v3xhae5447rgm
21 Jul 20
Entry into a Material Definitive Agreement
5:15pm
8-K
zae i0pcxv845
18 Jun 20
Submission of Matters to a Vote of Security Holders
4:05pm
DEFA14A
fwrwp7u
29 Apr 20
Additional proxy soliciting materials
5:28pm
8-K
qnxn2
30 Mar 20
Departure of Directors or Certain Officers
5:20pm
8-K
2xuwkm
2 Mar 20
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
4:51pm
S-8
1ngc pc7ezexrdhu
2 Mar 20
Registration of securities for employees
4:48pm
8-K
1rt05ua8ko7dc1
26 Feb 20
Entry into a Material Definitive Agreement
4:08pm
8-K
43bov1k 59o19tqb
10 Jan 20
Regulation FD Disclosure
8:46am
8-K
qmm3vrk7
8 Jan 20
Rhythm Pharmaceuticals Announces Leadership Transition
4:00pm
8-K
2yacab
6 Nov 19
Rhythm Pharmaceuticals Announces Late-breaking Data from Phase 3 Trials of Setmelanotide in POMC and LEPR Deficiency Obesities at ObesityWeek 2019
9:28am
8-K
zym0ruxkps0
1 Nov 19
Rhythm Pharmaceuticals Reports Third Quarter 2019 Financial Results
4:22pm